We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-6.45%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$440M
AUM Growth
+$68.3M
Cap. Flow
+$121M
Cap. Flow %
27.55%
Top 10 Hldgs %
7.16%
Holding
1,009
New
355
Increased
190
Reduced
143
Closed
321

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.33M
2
AZN icon
AstraZeneca
AZN
+$3.83M
3
SPB icon
Spectrum Brands
SPB
+$3.54M
4
BNS icon
Scotiabank
BNS
+$3.5M
5
TSN icon
Tyson Foods
TSN
+$3.37M

Top Sells

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$3.48M
2
DOV icon
Dover
DOV
+$2.95M
3
TU icon
Telus
TU
+$2.82M
4
SYK icon
Stryker
SYK
+$2.58M
5
TTWO icon
Take-Two Interactive
TTWO
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 18.71%
2 Technology 17.25%
3 Industrials 13.57%
4 Financials 13.31%
5 Consumer Discretionary 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNTV
676
DELISTED
Momentive Global Inc. Common Stock
MNTV
$98K 0.02%
+16,838
New +$131K
EAF icon
677
GrafTech
EAF
$203M
$97K 0.02%
2,252
-2,154
-49% -$137K
ERIC icon
678
Ericsson
ERIC
$33.6B
$95K 0.02%
+16,505
New +$118K
SGU icon
679
Star Group
SGU
$411M
$92K 0.02%
11,317
-9,638
-46% -$90.3K
YELL
680
DELISTED
Yellow Corporation Common Stock
YELL
$90K 0.02%
+17,662
New +$96.9K
VNET
681
VNET Group
VNET
$2.12B
$85K 0.02%
15,524
-16,182
-51% -$85.2K
CFFN icon
682
Capitol Federal Financial
CFFN
$1.09B
$84K 0.02%
+10,124
New +$94.1K
BV icon
683
BrightView Holdings
BV
$1.08B
$83K 0.02%
+10,458
New +$112K
MRSN
684
DELISTED
Mersana Therapeutics
MRSN
$81K 0.02%
+478
New +$77.7K
CCLD icon
685
CareCloud
CCLD
$104M
$72K 0.02%
+17,308
New +$69K
LTRX icon
686
Lantronix
LTRX
$272M
$69K 0.02%
14,304
+2,504
+21% +$15.2K
LFVN icon
687
LifeVantage
LFVN
$81.9M
$48K 0.01%
12,813
-1,074
-8% -$4.35K
ORGO icon
688
Organogenesis Holdings
ORGO
$226M
$46K 0.01%
+14,193
New +$64.1K
A icon
689
Agilent Technologies
A
$42.2B
-9,115
Closed -$1.08M
ABG icon
690
Asbury Automotive
ABG
$3.78B
-2,993
Closed -$507K
ADM icon
691
Archer Daniels Midland
ADM
$38.6B
-23,631
Closed -$1.83M
AEG icon
692
Aegon
AEG
$13.9B
-43,044
Closed -$184K
AGIO icon
693
Agios Pharmaceuticals
AGIO
$2B
-16,564
Closed -$367K
AIZ icon
694
Assurant
AIZ
$13.9B
-1,218
Closed -$211K
ALRM icon
695
Alarm.com
ALRM
$2.74B
-3,630
Closed -$225K
AMAT icon
696
Applied Materials
AMAT
$424B
-8,994
Closed -$818K
AMGN icon
697
Amgen
AMGN
$226B
-1,985
Closed -$483K
AMRX icon
698
Amneal Pharmaceuticals
AMRX
$6.02B
-28,223
Closed -$90K
ANSS
699
DELISTED
Ansys
ANSS
-995
Closed -$238K
APTV icon
700
Aptiv
APTV
$10.2B
-5,814
Closed -$518K

Similar funds

Campbell & Co Investment Adviser's Q3 2022 Portfolio in Review

As of Q3 2022, Campbell & Co Investment Adviser held 1,009 positions worth $440M, up 18% from $372M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Campbell & Co Investment Adviser deployed $121M of net new capital in Q3 2022, opening 355 new positions and adding to 190 existing holdings. Its largest new stake was GSK: 193,518 shares worth $5.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dover, an estimated $2.95M trimmed.

  • Campbell & Co Investment Adviser's largest Q3 2022 buy was GSK: 193,518 shares worth $5.7M.
  • Campbell & Co Investment Adviser added most to Scotiabank in Q3 2022, an estimated $3.5M increase.
  • Campbell & Co Investment Adviser's biggest Q3 2022 reduction was Dover, cutting an estimated $2.95M.
  • Campbell & Co Investment Adviser fully exited Virtu Financial in Q3 2022, selling an estimated $3.48M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 7.2% of its $440M portfolio in Q3 2022.
  • Campbell & Co Investment Adviser opened 355 new positions and closed 321 in Q3 2022.
  • Campbell & Co Investment Adviser's portfolio value rose 18% quarter-over-quarter to $440M.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2022, filed 14 Nov 2022.